Is Serum Human Chorionic Gonadotrophin Follow-up Necessary After Suspected Spillage of Trophoblast at the Time of Laparoscopic Surgery for Ectopic Pregnancy?
Overview
Affiliations
Background: Persistent trophoblast is a recognised complication of salpingostomy for the treatment of ectopic pregnancy, with reported rates of 3-20%; hence, women are advised to have serum human chorionic gonadotrophin (hCG) levels monitored post-operatively. Although much less common, there are also reports of disseminated trophoblastic peritoneal implants after laparoscopic salpingectomy. The aim of this study was to assess whether monitoring of post-operative serum hCG levels is necessary in women undergoing salpingectomy, where intra-operative spillage of trophoblast is thought to have occurred.
Methods: This was a retrospective study of women who underwent serum hCG follow-up after salpingectomy. Serum hCG levels were monitored if: (1) the ectopic pregnancy was found to be ruptured; (2) there was a significant haemoperitoneum (>500 ml); (3) there was thought to be spillage of trophoblast at the time of salpingectomy or (4) a tubal miscarriage was diagnosed. Serum hCG levels were taken at days 1-2, days 3-4, days 6-8 or days 13-15 post-surgery. Women were followed up until the serum hCG level was <15 IU/l. Persistent trophoblast was defined as a failure of the serum hCG level to decrease spontaneously after surgery.
Results: 105 women underwent serum hCG follow-up after a laparoscopy for a tubal ectopic pregnancy. Of these women, 92 had a laparoscopic salpingectomy and 13 were diagnosed with a tubal miscarriage at the time of laparoscopy. In all women the serum hCG decreased spontaneously.
Conclusion: It does not appear necessary to routinely monitor serum hCG levels post-operatively in women diagnosed with tubal miscarriages, in those undergoing salpingectomy for a ruptured ectopic pregnancy or in cases of salpingectomy, where there is thought to be spillage of trophoblast.
Larrain D, Caradeux J Obstet Gynecol Int. 2024; 2024:8351132.
PMID: 38486788 PMC: 10940029. DOI: 10.1155/2024/8351132.
Robson D, Lusink V, Campbell N Case Rep Womens Health. 2019; 21:e00095.
PMID: 30723694 PMC: 6350100. DOI: 10.1016/j.crwh.2019.e00095.
Refaat B, Dalton E, Ledger W Reprod Biol Endocrinol. 2015; 13:30.
PMID: 25884617 PMC: 4403912. DOI: 10.1186/s12958-015-0025-0.